Genomic landscape of high-grade T1 micropapillary bladder tumors.

被引：0
|
作者：
Bellmunt, Joaquim
Guo, Guangwu
Mullane, Stephanie A.
Orsola, Anna
Werner, Lillian
Van Hummelen, Paul
Thorner, Aaron
Loda, Massimo
Choueiri, Toni K.
Barletta, Justine A.
Kwiatkowski, David J.
Meyerson, Matthew
Van Allen, Eliezer Mendel
机构：
[1] Univ Hosp Mar, IMIM, Barcelona, Spain
[2] Broad Inst, Cambridge, MA USA
[3] Dana Farber Canc Inst, Bladder Canc Ctr, Brigham & Womens Canc Ctr, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[9] Harvard Univ, Brigham & Womens Hosp, Massachusetts Gen Hosp,MIT, Dana Farber Canc Inst,Sch Med,Broad Inst Harvard, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.299
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
299
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of high-grade T1 bladder cancer
    Medeiros, Mariana Silva
    de Carvalho, Luis Andre Botelho
    Alves, Marta
    Papoila, Ana
    dos Santos, Hugo Miguel Baptista Carreira
    Capelo-Martinez, Jose-Luis
    Pinheiro, Luis Manuel Viegas de Campos
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (08) : 2577 - 2587
  • [42] Depth of Invasion in High-Grade T1 Bladder Cancer: Added Value In Timely Cystectomy? Reply
    Martin-Doyle, William
    Orsola, Anna
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) : 2716 - 2717
  • [43] How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?
    Shariat, Shahrokh
    Gontero, Paolo
    Catto, James W. F.
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (04): : 663 - 669
  • [44] How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
    Yun, Seok Joong
    Kim, Seon-Kyu
    Kim, Wun-Jae
    INVESTIGATIVE AND CLINICAL UROLOGY, 2016, 57 : S44 - S51
  • [45] Intravesical Mitomycin Therapy for Stage T1 and Tis High-Grade Squamous Cell Carcinoma of the Bladder
    Delto, Joan C.
    Kacker, Ravi
    Bubley, Glenn
    DeWolf, William C.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (01) : E35 - E36
  • [46] Prognosis in high-grade T1 bladder cancer: host immune response and tumour infiltrating lymphocytes
    Lee, Su-Min
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S335 - S336
  • [47] The unique genomic landscape of pediatric high-grade glioma
    Larson, Jon D.
    Silveira, Andre B.
    Kasper, Lawryn H.
    Russell, Helen R.
    Qu, Chunxu
    McKinnon, Peter J.
    Baker, Suzanne J.
    CANCER RESEARCH, 2015, 75
  • [48] Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis
    Nomura, Shunichiro
    Suzuki, Yasutomo
    Takahashi, Ryo
    Terasaki, Mika
    Kimata, Ryoji
    Hamasaki, Tsutomu
    Kimura, Go
    Shimizu, Akira
    Kondo, Yukihiro
    BMC UROLOGY, 2013, 13
  • [49] Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis
    Shunichiro Nomura
    Yasutomo Suzuki
    Ryo Takahashi
    Mika Terasaki
    Ryoji Kimata
    Tsutomu Hamasaki
    Go Kimura
    Akira Shimizu
    Yukihiro Kondo
    BMC Urology, 13
  • [50] Delta-like ligand 3 immunohistochemical expression landscape in high-grade lung neuroendocrine tumors.
    Lima, Cibelle F.
    Rocha, Pedro S.
    Fujimoto, Junya
    Stewart, Allison
    Cardnell, Robert
    Lu, Wei
    Khan, Khaja
    Sable, Beate
    Ellison, Aaron R.
    Wistuba, Ignacio I.
    Gay, Carl M.
    Kalhor, Neda
    Byers, Lauren A.
    Solis-Soto, Luisa M.
    CANCER RESEARCH, 2022, 82 (12)
12345